STRATA Skin Sciences, Inc. — Director's Dealing 2011

Nov 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2011-11-01

Reporting Person: Gulfo Joseph V (Director, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-11-01	Stock Option	$3.75	A	540000	Acquired	2018-10-10	Common Stock (540000)	Direct

Footnotes

F1: The option grant was made by the Issuer's Board of Directors on October 10, 2008, with vesting of the options conditioned upon approval by the U.S. Food and Drug Administration ("FDA") of the Issuer's pre-market approval ("PMA") application for MelaFind. The FDA approved the MelaFind PMA on November 1, 2011. In accordance with the SEC's rules and regulations, the option grant is now being reported by the Reporting Person; however, the option grant has already been reported by the Issuer in its reports previously filed with the SEC.